IP Library › Assignment 047172/0481
Patent Assignment
Reel/Frame 047172/0481

Security Interest

Recorded: 2018-10-01 Pages: 12
Assignor
KALA PHARMACEUTICALS, INC.
Executed: 2018-10-01
Assignee
ATHYRIUM OPPORTUNITIES III ACQUISITION LP
530 FIFTH AVENUE, FLOOR 25, NEW YORK, NEW YORK, 10036
Covered Properties (70)
Nanocrystals, Compositions, and Methods That Aid Particle Transport in Mucus
Compositions and Methods Utilizing Poly (Vinyl Alcohol) and/or Other Polymers That Aid Particle Transport in Mucus
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Therapeutic Compounds and Uses Thereof
Therapeutic Compounds and Uses Thereof
Urea Derivatives and Uses Thereof
Compositions and Methods for Ophthalmic and/or Other Applications
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Particles, Compostitions, and Methods for Ophthalmic and/or Other Applications
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Functionalized Poly(Ether-Anhydride) Block Copolymers
Patent: 8,354,476 →
Application: 11/721,123 →
Publication: US 2010/0003337
Compositions and Methods Utilizing Poly(Vinyl Alcohol) and/or Other Polymers That Aid Particle Transport in Mucus
Application: 13/886,514 →
Publication: US 2013/0316009
Therapeutic Compounds and Uses Thereof
Patent: 9,353,122 →
Application: 14/181,095 →
Publication: US 2014/0235634
Therapeutic Compounds and Uses Thereof
Patent: 9,353,123 →
Application: 14/184,886 →
Publication: US 2014/0235657
Urea Derivatives and Uses Thereof
Patent: 9,212,145 →
Application: 14/301,653 →
Publication: US 2015/0072986
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Patent: 9,458,169 →
Application: 14/530,092 →
Publication: US 2015/0125535
Therapeutic Compounds and Uses Thereof
Patent: 9,695,184 →
Application: 14/768,038 →
Publication: US 2016/0002254
Meropenem Derivatives and Uses Thereof
Patent: 9,725,451 →
Application: 14/777,018 →
Publication: US 2016/0039823
Compounds for Treatment of Diseases of Abnormal Angiogenesis or Aberrant Growth Factors and Uses Thereof
Patent: 9,988,386 →
Application: 14/894,214 →
Publication: US 2016/0137646
Urea Derivatives and Uses Thereof
Patent: 9,580,421 →
Application: 14/939,727 →
Publication: US 2016/0060264
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Patent: 9,790,232 →
Application: 14/981,105 →
Publication: US 2016/0115176
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
Patent: 9,688,688 →
Application: 15/032,595 →
Publication: US 2016/0257693
Therapeutic Compounds and Uses Thereof
Patent: 9,827,248 →
Application: 15/139,099 →
Publication: US 2016/0235761
Therapeutic Compounds and Uses Thereof
Patent: 9,877,970 →
Application: 15/139,107 →
Publication: US 2016/0237093
Therapeutic Compounds and Uses Thereof
Patent: 9,833,453 →
Application: 15/139,121 →
Publication: US 2016/0235753
Therapeutic Compounds and Uses Thereof
Patent: 9,861,634 →
Application: 15/139,135 →
Publication: US 2016/0237094
Urea Derivatives and Uses Thereof
Patent: 9,802,922 →
Application: 15/411,485 →
Publication: US 2017/0129876
Crystalline Forms of a Therapeutic Compound and Uses Thereof
Application: 15/529,969 →
Publication: US 2017/0313724
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Application: 15/534,448 →
Publication: US 2018/0057489
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Patent: 9,890,173 →
Application: 15/604,080 →
Publication: US 2017/0260193
Meropenem Derivatives and Uses Thereof
Application: 15/650,667 →
Publication: US 2017/0349590
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/694,252 →
Publication: US 2018/0065977
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/694,331 →
Publication: US 2018/0065978
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/694,383 →
Publication: US 2018/0065979
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/712,645 →
Publication: US 2018/0009824
Urea Derivatives and Uses Thereof
Application: 15/782,696 →
Publication: US 2018/0037572
Urea Derivatives and Uses Thereof
Application: 15/782,743 →
Publication: US 2018/0037573
Therapeutic Compounds and Uses Thereof
Application: 15/842,695 →
Publication: US 2018/0104246
Therapeutic Compounds and Uses Thereof
Application: 15/868,894 →
Publication: US 2018/0133225
Novel Compounds and Uses Thereof
Application: 15/970,740 →
Publication: US 2018/0251467
Novel Compounds and Uses Thereof
Application: 16/014,937 →
Publication: US 2019/0023710
Urea Derivatives and Uses Thereof
Application: 16/043,000 →
Publication: US 2018/0327389
Urea Derivatives and Uses Thereof
Application: 16/043,007 →
Publication: US 2018/0327390
Functionalized poly (ether-anhydride) block copolymers
Application: 60/635,280 →
Compositions and Methods Utilizing Poly(Vinyl Alcohol) and/or Other Polymers That Aid Particle Transport in Mucus
Application: 61/642,261 →
Therapeutic Compounds and Uses Thereof
Application: 61/765,487 →
Therapeutic Compounds and Uses Thereof
Application: 61/767,087 →
Meropenem Derivatives and Uses Thereof
Application: 61/789,335 →
Novel compounds and uses thereof
Application: 61/829,117 →
Urea Derivatives and Uses Thereof
Application: 61/833,853 →
Novel Compounds and Uses Thereof
Application: 61/898,719 →
Urea Derivatives and Uses Thereof
Application: 61/898,720 →
Therapeutic Compounds and Uses Thereof
Application: 61/898,741 →
Therapeutic Compounds and Uses Thereof
Application: 61/898,778 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 62/039,177 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 62/039,192 →
Crystalline Forms of A Therapeutic Compound and Uses Thereof
Application: 62/084,682 →
Urea Derivative and Uses Thereof
Application: 62/090,045 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 62/385,148 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 62/385,154 →
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 62/385,155 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application: 62/395,980 →
Particles, Compositions and Methods for Ophthalmic and/or Other Applications
Application: 62/395,984 →
Biochemical Binding of RET9 and VEGFR2 Inhibitors
Application: 62/575,280 →
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Application: 62/694,805 →
Particles, Compositions, and Methods for Ophthalmic and/or Other Applications
Application: 62/694,819 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Nov 30, 2010
From: KALA PHARMACEUTICALS, INC.
To: LUX VENTURES II, L.P.; LUX VENTURES II SIDECAR, L.P.; POLARIS VENTURE PARTNERS V, L.P.; POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.
Reel/Frame 025414/0032 →
Security Agreement Jul 19, 2011
From: KALA PHARMACEUTICALS, INC.
To: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
Reel/Frame 026611/0985 →
Release of Security Interest Mar 13, 2012
From: LIGHTHOUSE CAPTIAL PARTNERS VI, L.P.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 027850/0340 →
Release of Security Interest Mar 13, 2012
From: LUX VENTURES II, L.P.; LUX VENTURES II SIDECAR, L.P.; THIRD ROCK VENTURES, L.P.; POLARIS VENTURE PARTNERS V, L.P.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 027850/0171 →
Corrective Assignment to Correct the Name of the Assignor Previously Recorded on Reel 027850 Frame 0340. Assignor(S) Hereby Confirms the Correct Name of the Assignor Is Lighthouse Capital Partners Vi, L.P. Mar 15, 2012
From: LIGHTHOUSE CAPITAL PARTNERS VI, L.P.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 027870/0777 →
Nunc Pro Tunc Assignment Sep 24, 2012
From: HANES, JUSTIN; FU, JIE
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 029013/0866 →
Nunc Pro Tunc Assignment Sep 24, 2012
From: THE JOHNS HOPKINS UNIVERSITY
To: HANES, JUSTIN; FU, JIE
Reel/Frame 029013/0882 →
Nunc Pro Tunc Assignment Sep 24, 2012
From: HANES, JUSTIN; FU, JIE
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 029013/0893 →
Assignment of Assignor's Interest Jul 8, 2013
From: POPOV, ALEXEY; ENLOW, ELIZABETH M.; CHEN, HONGMING
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 030752/0016 →
Assignment of Assignor's Interest Jul 8, 2013
From: ENSIGN, LAURA M.; LAI, SAMUEL K.; YU, TAO; HANES, JUSTIN
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 030751/0828 →
Assignment of Assignor's Interest Jul 8, 2013
From: POPOV, ALEXEY; ENLOW, ELIZABETH M.; BOURASSA, JAMES; GARDNER, COLIN R.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 030751/0583 →
Assignment of Assignor's Interest Jul 9, 2013
From: POPOV, ALEXEY
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 030759/0231 →
Assignment of Assignor's Interest May 6, 2014
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032829/0966 →
Assignment of Assignor's Interest May 6, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0862 →
Assignment of Assignor's Interest May 6, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0986 →
Assignment of Assignor's Interest May 9, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0976 →
Assignment of Assignor's Interest May 9, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0803 →
Assignment of Assignor's Interest May 9, 2014
From: ASKEW, BEN
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032861/0868 →
Assignment of Assignor's Interest Aug 8, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO; NGUYEN, MINH NGOC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033493/0135 →
Assignment of Assignor's Interest Sep 25, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033818/0808 →
Assignment of Assignor's Interest Sep 25, 2014
From: ASKEW, BEN C
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 033818/0339 →
Assignment of Assignor's Interest Sep 25, 2014
From: ONG, WINSTON Z; NOWAK, PAWEL W; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033817/0698 →
Assignment of Assignor's Interest Sep 25, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033818/0457 →
Assignment of Assignor's Interest Sep 25, 2014
From: ONG, WINSTON Z; NOWAK, PAWEL W; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033820/0049 →
Assignment of Assignor's Interest Sep 25, 2014
From: ASKEW, BEN C
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 033818/0752 →